{"id":492250,"date":"2021-05-12T09:06:13","date_gmt":"2021-05-12T13:06:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/"},"modified":"2021-05-12T09:06:13","modified_gmt":"2021-05-12T13:06:13","slug":"aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/","title":{"rendered":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">May 12, 2021<\/span> \/PRNewswire\/ &#8212; AIkido Pharma Inc. (Nasdaq: AIKI) (&#8220;AIkido&#8221; or the &#8220;Company&#8221;) today announced it will be featured as a presenting company at the following investor conferences:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg\" title=\"(PRNewsfoto\/AIkido Pharma Incorporated)\" alt=\"(PRNewsfoto\/AIkido Pharma Incorporated)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Benzinga Global SmallCap Conference on <span class=\"xn-chron\">May 13, 2021<\/span>.<br \/>( <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3161209-1&amp;h=2258414288&amp;u=https%3A%2F%2Fwww.benzinga.com%2Fevents%2Fsmall-cap%2Fglobal%2F&amp;a=https%3A%2F%2Fwww.benzinga.com%2Fevents%2Fsmall-cap%2Fglobal%2F\" rel=\"nofollow noopener\">https:\/\/www.benzinga.com\/events\/small-cap\/global\/<\/a>\u00a0)<\/p>\n<p>Investor Summit Group&#8217;s Q2 Virtual Summit being held <span class=\"xn-chron\">May 17-19, 2021<\/span>.<br \/>( <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3161209-1&amp;h=1098356908&amp;u=https%3A%2F%2Finvestorsummitgroup.com%2F&amp;a=https%3A%2F%2Finvestorsummitgroup.com\" rel=\"nofollow noopener\">https:\/\/investorsummitgroup.com<\/a>\u00a0)<\/p>\n<p>LD Micro Invitational XI Investor Conference being held <span class=\"xn-chron\">June 8-10, 2021<\/span>.<br \/>( <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3161209-1&amp;h=245563451&amp;u=https%3A%2F%2Fldmicrojune2021.mysequire.com%2F&amp;a=https%3A%2F%2Fldmicrojune2021.mysequire.com\" rel=\"nofollow noopener\">https:\/\/ldmicrojune2021.mysequire.com<\/a>\u00a0)<\/p>\n<p>The Company will showcase an updated Investor Presentation and discuss some of its new technology.\u00a0Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will present for the Company.<\/p>\n<p>\n        <b>About AIkido Pharma Inc.<\/b>\n      <\/p>\n<p>AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer therapeutics.\u00a0 The Company&#8217;s platform consists of patented technology from leading universities and researchers, and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The\u00a0University of <span class=\"xn-location\">Texas<\/span> at Austin\u00a0and\u00a0University of <span class=\"xn-location\">Maryland<\/span> at <span class=\"xn-location\">Baltimore<\/span>. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. We are constantly seeking to grow our pipeline to treat unmet medical needs in oncology.\u00a0 The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>Certain statements in this press release constitute &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws. Words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;predict,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;intend&#8221; or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company&#8217;s filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<p>Investor Relations:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0 Hayden IR<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Brett Maas, Managing Partner<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0 Phone: (646) 536-7331<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0 Email: <a target=\"_blank\" href=\"mailto:brett@haydenir.com\" rel=\"nofollow noopener\">brett@haydenir.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0 <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3161209-1&amp;h=1818985056&amp;u=http%3A%2F%2Fwww.haydenir.com%2F&amp;a=www.haydenir.com\" rel=\"nofollow noopener\">www.haydenir.com<\/a><\/p>\n<p>AIkido Pharma Inc.:\u00a0\u00a0\u00a0 <\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0 Phone: 212-745-1373<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Email: <a target=\"_blank\" href=\"mailto:investorrelations@aikidopharma.com\" rel=\"nofollow noopener\">investorrelations@aikidopharma.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3161209-1&amp;h=1283746396&amp;u=http%3A%2F%2Fwww.aikidopharma.com%2F&amp;a=www.aikidopharma.com\" rel=\"nofollow noopener\">www.aikidopharma.com<\/a><\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY75317&amp;sd=2021-05-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference-301289776.html\">http:\/\/www.prnewswire.com\/news-releases\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference-301289776.html<\/a><\/p>\n<p>SOURCE  AIkido Pharma Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY75317&amp;Transmission_Id=202105120900PR_NEWS_USPR_____NY75317&amp;DateId=20210512\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, May 12, 2021 \/PRNewswire\/ &#8212; AIkido Pharma Inc. (Nasdaq: AIKI) (&#8220;AIkido&#8221; or the &#8220;Company&#8221;) today announced it will be featured as a presenting company at the following investor conferences: Benzinga Global SmallCap Conference on May 13, 2021.( https:\/\/www.benzinga.com\/events\/small-cap\/global\/\u00a0) Investor Summit Group&#8217;s Q2 Virtual Summit being held May 17-19, 2021.( https:\/\/investorsummitgroup.com\u00a0) LD Micro Invitational XI Investor Conference being held June 8-10, 2021.( https:\/\/ldmicrojune2021.mysequire.com\u00a0) The Company will showcase an updated Investor Presentation and discuss some of its new technology.\u00a0Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will present for the Company. About AIkido Pharma Inc. AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-492250","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#039;s Conference, and the LD Micro Invitational Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#039;s Conference, and the LD Micro Invitational Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, May 12, 2021 \/PRNewswire\/ &#8212; AIkido Pharma Inc. (Nasdaq: AIKI) (&#8220;AIkido&#8221; or the &#8220;Company&#8221;) today announced it will be featured as a presenting company at the following investor conferences: Benzinga Global SmallCap Conference on May 13, 2021.( https:\/\/www.benzinga.com\/events\/small-cap\/global\/\u00a0) Investor Summit Group&#8217;s Q2 Virtual Summit being held May 17-19, 2021.( https:\/\/investorsummitgroup.com\u00a0) LD Micro Invitational XI Investor Conference being held June 8-10, 2021.( https:\/\/ldmicrojune2021.mysequire.com\u00a0) The Company will showcase an updated Investor Presentation and discuss some of its new technology.\u00a0Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will present for the Company. About AIkido Pharma Inc. AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer &hellip; Continue reading &quot;AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-12T13:06:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference\",\"datePublished\":\"2021-05-12T13:06:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/\"},\"wordCount\":459,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/\",\"name\":\"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"datePublished\":\"2021-05-12T13:06:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/","og_locale":"en_US","og_type":"article","og_title":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference - Market Newsdesk","og_description":"PR Newswire NEW YORK, May 12, 2021 \/PRNewswire\/ &#8212; AIkido Pharma Inc. (Nasdaq: AIKI) (&#8220;AIkido&#8221; or the &#8220;Company&#8221;) today announced it will be featured as a presenting company at the following investor conferences: Benzinga Global SmallCap Conference on May 13, 2021.( https:\/\/www.benzinga.com\/events\/small-cap\/global\/\u00a0) Investor Summit Group&#8217;s Q2 Virtual Summit being held May 17-19, 2021.( https:\/\/investorsummitgroup.com\u00a0) LD Micro Invitational XI Investor Conference being held June 8-10, 2021.( https:\/\/ldmicrojune2021.mysequire.com\u00a0) The Company will showcase an updated Investor Presentation and discuss some of its new technology.\u00a0Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will present for the Company. About AIkido Pharma Inc. AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer &hellip; Continue reading \"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-12T13:06:13+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference","datePublished":"2021-05-12T13:06:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/"},"wordCount":459,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/","name":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","datePublished":"2021-05-12T13:06:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-inc-to-present-at-the-benzinga-global-small-cap-conference-the-investor-summit-groups-conference-and-the-ld-micro-invitational-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group&#8217;s Conference, and the LD Micro Invitational Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/492250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=492250"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/492250\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=492250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=492250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=492250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}